Cambodia

The primary regulatory authority for health products in Cambodia is the Department of Drugs and Food (DDF) under the Ministry of Health. The DDF oversees the registration, licensing, and post-market surveillance of pharmaceuticals, medical devices, diagnostics, and related health products. The principal governing legislation includes the Law on the Management of Pharmaceuticals (1996) and subsequent sub-decrees and ministerial guidelines that regulate product registration, importation, distribution, and quality control. All health products must undergo a formal registration process before they may be legally marketed or distributed in Cambodia. Applicants are required to submit a registration dossier to the DDF, which evaluates safety, efficacy, and quality. The review process involves technical assessment by DDF committees, and products may be subject to laboratory testing prior to approval. Registration certificates are typically valid for a defined period, after which renewal is required.

Foreign manufacturers seeking market authorization in Cambodia must appoint a locally registered importer or authorized representative who bears legal responsibility for the product within the country. Dossier submissions generally follow the ASEAN Common Technical Dossier (ACTD) format, consistent with Cambodia's membership in the ASEAN harmonization framework, though the degree of enforcement and alignment with ACTD standards continues to evolve. Cambodia participates in ASEAN regulatory harmonization initiatives, and the DDF has been progressively updating its guidelines to align with regional standards. Recent reform efforts, supported by international partners including the World Health Organization, have focused on strengthening regulatory capacity, introducing electronic registration systems, and improving transparency in the registration process. Applicants should note that timelines can vary significantly depending on product category, completeness of the dossier, and current DDF workload.

Public procurement of health products in Cambodia is primarily coordinated through the Ministry of Health, with the Department of Hospital Services and the Central Medical Store (CMS) playing key roles in forecasting, tendering, warehousing, and distributing essential medicines, medical devices, and diagnostics to public health facilities. National procurement is governed by the Law on Public Procurement and related sub-decrees administered by the Ministry of Economy and Finance, which sets out competitive tendering requirements, supplier qualification criteria, and contract management procedures. The National Tender Committee, in coordination with the Ministry of Health, oversees larger procurement contracts, while health facilities at the provincial and district levels may conduct smaller, decentralized purchases within defined thresholds. Budget constraints in the public sector mean that procurement volumes and timelines can be affected by annual government budget cycles and external funding availability.

Cambodia's health sector remains significantly supported by international donors and multilateral agencies, which constitute an important parallel procurement channel alongside government budgets. Organizations such as UNICEF, the Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID, the World Bank, and Gavi, the Vaccine Alliance, fund and in some cases directly procure health commodities for programs targeting HIV, tuberculosis, malaria, maternal and child health, and immunization. These procurement processes typically follow the respective agency's own procurement rules and prequalification requirements, such as WHO prequalification or stringent regulatory authority approval, meaning suppliers must meet international quality standards in addition to local registration requirements. Local manufacturing capacity in Cambodia remains limited, and there are currently no strong formal local manufacturing preference policies in place; however, the government has expressed strategic interest in developing domestic pharmaceutical production capacity as part of longer-term health security goals. Private sector procurement occurs through licensed importers and distributors supplying private hospitals, clinics, and pharmacies, with purchasing decisions driven largely by price competitiveness, supplier relationships, and product availability.